PCOS (Polycystic Ovarian Syndrome) Patients

Recruiting

• Conditions: Health Related

• Registration Number: NCT03991507
• Lead Sponsor: The First Affiliated Hospital of Zhengzhou University

Brief Summary

The Prospective Cohort Study for PCOS Patients was set up to investigate the short- and long-term health consequences in Reproductive Medical Center, First Affiliated Hospital of Zhengzhou University, China.

Detailed Description

Polycystic ovary syndrome (PCOS) affects 8-13% of women. It is a multifaceted condition characterized by chronic anovulation and excess ovarian activity.

Since last decade, Clinical Reproductive Medicine Management System/Electronic Medical Record Cohort Database (CCRM/EMRCD) has been used in Reproductive Medical Center, First Affiliated Hospital of Zhengzhou University, and Henan Province Key Laboratory for Reproduction and Genetics. Information of patients (POI, PCOS, Endometriosis, azoospermia, ect) were recorded comprehensively. The current project plans to recruit PCOS participants in our center. Biological samples, questionnaires and short/long term health data will be collected. The study is aimed to provide evidence for PCOS prognosis.

Study Timeline

• Study Start: 2010-01-01
• Status Verified: 2019-06
• Study First Submitted: 2019-06-13
• Study First Submitted QC: 2019-06-18
• Last Update Submitted: 2019-06-18
• Study First Posted: 2019-06-19
• Last Update Posted: 2019-06-19
• Primary Completion: 2050-12-31
• Study Completion: 2050-12-31

Recruitment & Eligibility

• Status: RECRUITING
• Sex: Female
• Target Recruitment: 10000

Inclusion Criteria

• PCOS patients diagnosed with The Rotterdam diagnostic criteria.

Exclusion Criteria

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Level of serum FSH (Follicle stimulating hormone)	From date of inclusion, assessed by each 12 month, up to 40 years	mIU/mL
Level of serum LH (Luteinizing hormone)	From date of inclusion, assessed by each 12 month, up to 40 years	mIU/mL
Level of T (Testosterone)	From date of inclusion, assessed by each 12 month, up to 40 years	ng/ml

Secondary Outcome Measures

Name	Time	Method
Body Weight	From date of inclusion, assessed by each 12 month, up to 40 years	Recorded in Kilograms
Height	From date of inclusion, assessed by each 12 month, up to 40 years	Recorded in centimeters

Trial Locations

Locations (1)

Reproductive Medical Center, First Affiliated Hospital of Zhengzhou University; 🇨🇳 Zhengzhou, Henan, China